Stock Events

Stock Events

Capricor Therapeutics (CAPR) Q3 2026 Earnings

13AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-0.7

-0.63

-0.55

-0.48

Details

Expected EPS

-0.588889

Actual EPS

-0.7

Surprise EPS

-0.11

Surprise Percent

+18.87%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.7 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.